Home Cart Sign in  
Chemical Structure| 479-18-5 Chemical Structure| 479-18-5

Structure of 479-18-5

Chemical Structure| 479-18-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dyphylline, a xanthine derivative, acts as an adenosine receptor antagonist and phosphodiesterase inhibitor, which is used in the treatment of respiratory disorders.

Synonyms: Diprophylline; Diphylline; Neothylline

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 7-(2,3-Dihydroxypropyl)theophylline

CAS No. :479-18-5
Formula : C10H14N4O4
M.W : 254.24
SMILES Code : O=C(N1C)N(C)C2=C(N(CC(O)CO)C=N2)C1=O
Synonyms :
Diprophylline; Diphylline; Neothylline
MDL No. :MFCD00005759

Safety of 7-(2,3-Dihydroxypropyl)theophylline

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of 7-(2,3-Dihydroxypropyl)theophylline

GPCR

Isoform Comparison

Biological Activity

Description
Diphylline (Diprophylline) is an A1/A2 adenosine receptor antagonist and a cyclic nucleotide phosphodiesterase inhibitor. As a xanthine derivative, Diphylline acts as a bronchodilator and vasodilator and is potentially useful for treating chronic bronchitis and emphysema[1].[2].
Target
  • PDE

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00345930 - Recruiting July 2022 United States, California ... More >> University of Southern California Recruiting Los Angeles, California, United States, 90033 Contact: Susan Milstein, RN, BSN    323-224-5441    smilstei@usc.edu    Contact: None Available          Principal Investigator: Andrew Stolz, MD          United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202-5111 Contact: Audrey Corne, RN ,EdD    317-278-3062    acorne@iu.edu    Principal Investigator: Naga P Chalasani, MD          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109-0362 Contact: Ben Johnson    734-936-4886    kendalld@med.umich.edu    Principal Investigator: Robert J Fontana, MD          United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Stephanie Pagan       stephanie.pagan@mssm.edu    Contact: Jospeph odin, MD    212-241-8035    joseph.odin@mountsinai.org    United States, North Carolina Univeristy of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599-7600 Contact: Tracy Russell    919-843-2376    trussell@med.unc.edu    Contact: None Available          Principal Investigator: Paul B Watkins, MD          United States, Pennsylvania Albert Einstein Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Manisha Verma, MD MPH    215-456-2480    VegaMari@einstein.edu    Principal Investigator: Victor J Navarro, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.93mL

0.79mL

0.39mL

19.67mL

3.93mL

1.97mL

39.33mL

7.87mL

3.93mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories